Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029093
Filing Date
2022-08-11
Accepted
2022-08-11 15:09:59
Documents
53
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-10q_20220630.htm   iXBRL 10-Q 2302895
2 EX-31.1 etnb-ex311_7.htm EX-31.1 20141
3 EX-31.2 etnb-ex312_6.htm EX-31.2 20154
4 EX-32 etnb-ex32_8.htm EX-32 15938
  Complete submission text file 0001564590-22-029093.txt   7484527

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA etnb-20220630.xsd EX-101.SCH 39572
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE etnb-20220630_cal.xml EX-101.CAL 48083
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE etnb-20220630_def.xml EX-101.DEF 140075
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20220630_lab.xml EX-101.LAB 373064
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20220630_pre.xml EX-101.PRE 262764
47 EXTRACTED XBRL INSTANCE DOCUMENT etnb-10q_20220630_htm.xml XML 1376397
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 221155302
SIC: 2834 Pharmaceutical Preparations